Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.
Autorzy:
Chitnis T; Department of Neurology Partners Multiple Sclerosis Center Brigham and Women's Hospital Boston Massachusetts.; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Gonzalez C; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Healy BC; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115.; Massachusetts General Hospital Biostatistics Center Boston Massachusetts. Saxena S; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Rosso M; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Barro C; Departments of Medicine, Biomedicine and Clinical Research Neurologic Clinic and Policlinic University Hospital Basel University of Basel Basel Switzerland. Michalak Z; Departments of Medicine, Biomedicine and Clinical Research Neurologic Clinic and Policlinic University Hospital Basel University of Basel Basel Switzerland. Paul A; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Kivisakk P; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Diaz-Cruz C; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Sattarnezhad N; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Pierre IV; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Glanz BI; Department of Neurology Partners Multiple Sclerosis Center Brigham and Women's Hospital Boston Massachusetts.; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Tomic D; Novartis Neuroscience Development Unit Basel Switzerland. Kropshofer H; Novartis Neuroscience Development Unit Basel Switzerland. Häring D; Novartis Neuroscience Development Unit Basel Switzerland. Leppert D; Novartis Neuroscience Development Unit Basel Switzerland. Kappos L; Departments of Medicine, Biomedicine and Clinical Research Neurologic Clinic and Policlinic University Hospital Basel University of Basel Basel Switzerland. Bakshi R; Department of Neurology Partners Multiple Sclerosis Center Brigham and Women's Hospital Boston Massachusetts.; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Weiner HL; Department of Neurology Partners Multiple Sclerosis Center Brigham and Women's Hospital Boston Massachusetts.; Harvard Medical School Boston Massachusetts 02115.; Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115. Kuhle J; Departments of Medicine, Biomedicine and Clinical Research Neurologic Clinic and Policlinic University Hospital Basel University of Basel Basel Switzerland.
A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
